share_log

华润医药(03320.HK):完成涉及华润圣火的建议内部重组

CHINARES PHARMA (03320.HK): Completed the proposed internal restructuring involving China Resources Shengkai.

Gelonghui Finance ·  Dec 20 17:12

On December 20, Gelonghui reported that CHINARES PHARMA (03320.HK) announced a proposed internal restructuring involving its non-wholly owned subsidiary, Kunming CHINARES Shenghuo Pharmaceutical Co., Ltd. ("CHINARES Shenghuo"). On December 20, 2024, according to the terms of the Equity Transfer Agreement, China Resources Sanjiu Medical & Pharmaceutical proposed to transfer 51% equity in CHINARES Shenghuo to Kunming Pharmaceutical. The trade has completed business registration, and the transfer has been finalized.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment